Lapatinib Completed Phase 2 Trials for Gliomas / Glioblastoma Multiforme (GBM) / GS / Gliosarcoma / Neoplasms, Brain / GBM Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00107003GW572016 to Treat Recurrent Malignant Brain Tumors
NCT00350727Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma